Anavex Life Sciences Corp.
AVXL • NASDAQ
Anavex Life Sciences Corp. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher U. Missling, with a market cap of $261.3M.
Market Cap$261.3M
Employees40.0
CEOChristopher U. Missling
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ2 2026
Financials
Anavex Life Sciences Corp. FAQ
Common questions about Anavex Life Sciences Corp.
Anavex Life Sciences Corp. is scheduled to report earnings for Q2 2026 on May 12, 2026.
Anavex Life Sciences Corp. has approximately 40 employees.